The success of GLP-1 receptor agonists/analogues has transformed metabolic disease treatment while demonstrating the potential of engineered peptides to deliver long-acting, highly targeted therapies.

Rep. David Rowe, Chairman of the Pennsylvania House Republican Policy Committee, far right, conducted a hearing on Tuesday at the Friedman JCC in Kingston titled ‘Small Communities, Big Costs: ...

AI agents are now being weaponized through prompt injection, exposing why model guardrails are not enough to protect enterprise data. If you can only read one tech story a day, this is it. We use ...

Ranked by Value of all metro-area SBA loans in 2025 Ranked by Total local employees Ranked by Total Closings Wilmington Trust is pleased to welcome Kristen Stevenson as a Senior Wealth Advisor in its… ...